Decoding the Metabolome with Mass Spectrometry
Webinar

Decoding the Metabolome with Mass Spectrometry

In this webinar, Gary Patti and Arash Zarrine-Afsar will highlight advances in mass spectrometry that accelerate metabolic research and clinical discovery.

Share

This webinar will be hosted live and available on-demand

Friday, November 14th, 2025
11:00 AM - 12:30 PM ET

Mass spectrometry-based metabolomics is transforming how researchers study metabolism in health and disease, from basic cellular pathways to complex organismal interactions. Scientists face challenges in both identifying unknown metabolites in complex datasets and rapidly profiling tissues in the laboratory and clinic. Integrating new analytical methods and computational tools allows researchers to decode complex metabolomes and generate rapid molecular signatures for clinical applications.

In this webinar brought to you by The Scientist, Gary Patti and Arash Zarrine-Afsar will discuss how scientists are advancing human health and disease research by using next-generation mass spectrometry techniques for metabolomics analysis.

Topics to be covered

  • Using experimental and computational mass spectrometry advances to identify unknown metabolites and map gut microbiome-influenced metabolic pathways
  • Leveraging 10-second lipidomic analysis with picosecond infrared laser mass spectrometry to accurately distinguish pediatric and adult brain cancer types
 
      Gary Patti, PhD


Gary Patti, PhD
Professor
Washington University in St. Louis

     
      Arash Zarrine-Afsar, PhD


Arash Zarrine-Afsar, PhD
Senior Scientist, Princess Margaret Cancer Centre
University Health Network
Associate Professor, Departments of Surgery and Medical Biophysics
University of Toronto


Top Image Credit:

iStock: ismagilov

Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies